- Autoimmune skin disease
- Balanitis
- Confluent and reticulated papillomatosis (CARP)
- Contact dermatitis
- CREST syndrome
- Cutaneous lupus
- Dermatitis
- Dermatomyositis
- Discoid lupus
- Discoid lupus erythematosus (DLE)
- En coup de sabre
- Extragenital lichen sclerosus
- Facial hemiatrophy
- Graft versus host disease (GvHD)
- Interface dermatitis
- Itching
- Lichen sclerosus
- Linear morphea
- Lupus
- Mixed connective tissue disease (MCTD)
- Morphea
- Rheumatic skin diseases
- Scleroderma
- Shingles
- Sjogren's syndrome
- Skin cancer
- Skin graft versus host disease (GvHD)
- Skin rash
- Subacute cutaneous lupus erythematosus (SCLE)
- Systemic sclerosis (SSc)
- Tumid lupus (Lupus erythematosus tumidus)
Emily Lynde Baumrin, MD, MSCE
she/her
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
Penn Medicine Provider
About me
- Director, Graft-versus-host Disease Subspecialty Clinic, Department of Dermatology
- Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
- Assistant Professor of Dermatology in Medicine (Hematology-Oncology)
Dr. Emily Baumrin is a dermatologist and internal medicine physician who treats patients with dermatologic diseases. Her research aims to improve the lives of patients suffering from dermatologic complications of transplantation and cancer therapies, including graft-versus-host disease (GVHD). She leads a research program that focuses on understanding skin GVHD, and the best ways to prevent, diagnose and treat this condition. She serves as director of Penn Dermatology’s Graft-versus-host Disease Multi-disciplinary Clinic.
My education and training
- Medical School: University of Pennsylvania School of Medicine
- Residency: Mass General Brigham Healthcare Center - Chestnut Hill
Spoken languages
English
English
Español
Spanish
Reviews
297 reviews
Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
- Pennsylvania Hospital: Has privileges to treat patients in the hospital.
- Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Qualifications and experience
- Dermatology
- Internal Medicine, 2020
- American Academy of Dermatology, National
- Medical Dermatology Society, National
- Oncodermatology Society, International
- Philadelphia Dermatological Society, Local
- Society of Dermatology Hospitalists, National
- Society of Investigative Dermatology, International
- Penn Telomere Biology Disorders Program
Treatments and conditions
Research
Publications
Alvarado S, Tran VA, Werth VP, Baumrin E. Chronic GVHD has similar or worse impact on skin-specific quality of life than autoimmune connective tissue diseases: a cross-sectional study , J Am Acad Dermatol: 2026
Babu V, Shin DB, Onstad L, Pidala JA, Chen G, Lee CJ, Kitko CL, Carpenter PA, Cutler C, El Jurdi N, Loren AW, Gelfand JM, Lee SJ, Baumrin E. Discordance in Treatment Response Assessment Between Clinicians and Patients with Skin Chronic Graft-vs-Host Disease , JAMA Dermatol: 2026
Lazarow H, Carulli A, McWilliams T, Kucharczuk C, Hollander L, Catania C, Munshi P, Gabriel P, Loren A, Porter D, Baumrin E Vitamin C deficiency in allogeneic hematopoietic cell transplantation recipients in the peri-transplant period , Support Care Cancer, 33: 2025,755
Baumrin E, Pidala J, Mitchell S, Onstad L, Lee S Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated sclerosis , Blood, 145(12): 2025,1321-332
Baumrin E, Cronholm P, Kearney M, Mengesha M, Cesar L, Keddem S, Schapira M, Lee S, Loren A, Gelfand J Outcomes of Importance to Patients Living with Cutaneous Chronic Graft-vs-Host Disease , JAMA Dermatol, 161(3): 2025,281-90
Alvarado SM, Cohen OG, Lattanzio K, Haun P, Gelfand JM, Loren AW, Chung J, Baumrin E Histopathologic Analysis of Chronic Cutaneous Graft-Versus-Host Disease , Am J Dermatopathol, 46(11): 2024,755-60
Pidala J, Onstad L, Baumrin E, Carpenter P, Cutler C, Arai S, Kitko C, Chen G, Lee S Comparison of treatment response measures in cutaneous sclerosis after allogeneic hematopoietic cell transplantation , Blood Adv, 8(17): 2024,4651-657
Choe J, Shields A, Ferreira A, Gold S, Gotschall J, Kamal K, Rios A, Wang R, Baumrin E, Dommasch E, Yeung H, Lipoff J, Barbieri J Isotretinoin for Acne in Transgender and Gender-Diverse Individuals Receiving Masculinizing Hormone Therapy , JAMA Dermatol, 160(7): 2024,741-45
Baumrin E, Shin D, Mitra N, Pidala J, Jurdi N, Lee S, Loren A, Gelfand J Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease , JAMA Dermatol, 160(4): 2024,393-401
Rastogi S, Kim E, Gelfand J, Loren A, Baumrin E Chronic Graft-versus-Host Disease-Associated Muscle Cramps: Severity and Response to Immunomodulatory Therapies , Transplant Cell Ther, 30(3): 2024,338